SCHEMBL27700429

SCHEMBL27700429

CN(O[SH](=O)=O)c1ccc(Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.41
▸ HPGD P15428 2/20 0.41
▸ ALOX15 P16050 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ TDP1 Q9NUW8 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ CHRNB2 P17787 1/20 0.37
▸ CHRNB4 P30926 1/20 0.37
▸ CHRNA3 P32297 1/20 0.37
▸ CHRNA4 P43681 1/20 0.37
▸ CHKA P35790 6/20 0.36
▸ PGR P06401 1/20 0.35
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA3 P07451 1/20 0.34
▸ CA4 P22748 1/20 0.34
▸ CA6 P23280 1/20 0.34
▸ CA5A P35218 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28168182 0.81 ALDH1A1 (0.46) ALDH1A1HPGDKDM4ETDP1POLB
SCHEMBL27450285 0.79 TDP1 (0.48) ALDH1A1ALOX15KDM4ETDP1MAPT
SCHEMBL28168179 0.79 APP (0.39) ALDH1A1HPGDALOX15KDM4EHSD17B10
SCHEMBL27294646 0.78 HTT (0.43) ALDH1A1ALOX15KDM4EPOLBCHRNB2
SCHEMBL27297501 0.76 CYP2A6 (0.55) ALDH1A1HPGDKDM4EHSD17B10LMNA
SCHEMBL27350154 0.75 — —
SCHEMBL27809709 0.75 ALDH1A1 (0.41) ALDH1A1TDP1CHRNB2CHRNB4CHRNA3
SCHEMBL27889712 0.73 ALDH1A1 (0.47) ALDH1A1HPGDALOX15KDM4EHSD17B10
SCHEMBL27787739 0.71 MAPT (0.42) ALDH1A1HPGDKDM4ETDP1CA12
SCHEMBL14167899 0.70 ALDH1A1 (0.43) ALDH1A1HPGDALOX15KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107056799-B The double heptene sulfamide compounds of suberic acid monoanilide group oxygen bridge, its synthetic method, application and anti-breast cancer medicines composition 武汉宏兹生物技术有限公司 2019-06-14 — — CN disclosed
CN-101495463-B Seven-membered ring compound, production method thereof and pharmaceutical use thereof DAIICHI SANKYO CO LTD 2012-08-15 — — CN disclosed
CN-102127023-A 7-membered ring compound, process for producing the same, and use thereof DAIICHI ASUBIO PHARMA CO LTD 2011-07-20 — — CN disclosed
CN-101160290-B 7-membered ring compound, process for producing the same, and pharmaceutical use thereof DAIICHI SANKYO CO LTD 2011-01-19 — — CN disclosed
CN-101495463-A Seven-membered ring compound, production method thereof and pharmaceutical use thereof ASUBIO PHARMA CO LTD (JP) 2009-07-29 — — CN disclosed
CN-101160290-A 7-membered ring compound, process for producing the same, and pharmaceutical use thereof ASUBIO PHARMA CO LTD (JP) 2008-04-09 — — CN disclosed
Send feedback